CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $139,463 | -40.4% | 7,498 | -58.8% | 0.01% | -50.0% |
| Q3 2022 | $234,000 | -28.7% | 18,202 | -61.1% | 0.01% | -6.7% |
| Q2 2022 | $328,000 | -15.5% | 46,759 | 0.0% | 0.02% | -6.2% |
| Q1 2022 | $388,000 | +12.5% | 46,759 | -8.1% | 0.02% | +33.3% |
| Q4 2021 | $345,000 | -8.5% | 50,895 | -28.5% | 0.01% | 0.0% |
| Q3 2021 | $377,000 | -19.3% | 71,187 | -12.4% | 0.01% | +9.1% |
| Q2 2021 | $467,000 | +24.5% | 81,249 | 0.0% | 0.01% | +22.2% |
| Q1 2021 | $375,000 | +14.7% | 81,249 | -17.0% | 0.01% | +28.6% |
| Q4 2020 | $327,000 | +4.5% | 97,912 | -6.9% | 0.01% | 0.0% |
| Q3 2020 | $313,000 | – | 105,219 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |